Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Active, not recruiting · NCT01838512
Conditions: Multiple Myeloma
At a glance
- Research payments reported, 2025
- $44,274
- U.S. investigators named
- 11
- Sites paid
- 10
- Planned or actual enrollment
- 2,555
About the trial
- Sponsor
- Bristol-Myers Squibb
- Dates
- Started 2012-06-13; completion 2030-03-31
- Results posted
- Not yet
The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.
From ClinicalTrials.gov, last updated 2025-12-02. Full record, eligibility and contacts (opens in a new tab)
Industry funding
E.r. Squibb & Sons, L.l.c. reported $44,274 in research payments for this study in 2025 (14 payments).
Products named: Empliciti
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Christopher G. Wang, M.D Hematology & Oncology · Birmingham, AL
- Mehdi M. Moezi, MD Hematology & Oncology · Fleming Island, FL
- Michael K. Chahin, DO Hematology & Oncology · Savannah, GA
- Donald B. Wender, M.D. Hematology & Oncology · Sioux City, IA
- Hira Latif, MD Hematology & Oncology · Baltimore, MD
- Ravi Vij, MD Medical Oncology · Saint Louis, MO
- Stacey K. Knox, MD Hematology & Oncology · Lincoln, NE
- Amir A. Faridi, M.D. Hematology & Oncology · Denison, TX
- Leonardo Forero, MD Medical Oncology · Amarillo, TX
- Tammy E. Roque, MD Medical Oncology · Sherman, TX
- Robert E. Richard, MD,PHD Hematology & Oncology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Cancer Specialists, Llc $12,173
- Washington University $6,790
- Southeast Nebraska Cancer Center $6,720
- Us Oncology Res Llc $4,875
- Medstar Research Institute $4,422
- Multiple Doctors $3,380
- Siouxland Hematology Oncology Associates $1,650
- Seattle Institute for Biomedical and Clinical Research $1,500
- Birmingham Hematology and Oncology Ass,llc $1,400
- Texas Onco Southwest Fort Worth $1,364
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.